Company profile: Cytoo
1.1 - Company Overview
Company description
- Provider of life science research products and cell-based assay solutions that make cellular analysis robust and reliable by decreasing cell variability, including high content screening (96-well, 384 format coming), micropatterning technology, OncoSpheres 3D spheroids, Arena and custom chips, and standard, starter, and motility plates for high-throughput, multiplexed analysis.
Products and services
- Micropatterning: Custom-engineered technology that controls the cellular microenvironment to enhance physiological relevance, improving differentiation and maturation for more predictive cellular models in research
- OncoSpheres™: Low-variability 3D spheroid cellular model with size interwell CV below 5%, enabling high-throughput image acquisition and read-out multiplexing for reliable, scalable screening
- High Content Screening: 96-well compatible cell-based assays combining robustness, multiplexed visual read-outs, and throughput, with a 384-well format coming soon for expanded imaging and analysis capacity
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cytoo
Hamilton Thorne
HQ: United States
Website
- Description: Provider of advanced laser systems and instruments for in-vitro cell applications in regenerative medicine research and fertility clinic markets. Offerings include ZILOS-tk and XYClone lasers that attach to inverted microscopes and act as robotic micro-surgeons; sperm analyzers and CASA platforms (IVOS II, TOX IVOS II), IVF equipment, and ZANDAIR PCOC3 in-duct air purification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hamilton Thorne company profile →
Graniten
HQ: Sweden
Website
- Description: Provider of machine solutions for pharmaceutical manufacturing and healthcare automation, offering the Graniten Flexline modular packaging platform for high-mix, low-volume formats with near-zero changeover, TS230 case packer/palletizer, customized packaging and healthcare automation solutions (e.g., laboratory automation), and augmented reality remote support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Graniten company profile →
Sartorius
HQ: Germany
Website
- Description: Provider of laboratory and process technologies and equipment for biopharmaceutical production and laboratory environments, offering bioprocess solutions including filtration, fermentation, and purification technologies, and lab products and services with instruments and consumables for research and quality control, helping develop and manufacture biotech medicines reliably, quickly, and economically.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sartorius company profile →
Standard BioTools
HQ: United States
Website
- Description: Provider of microfluidic-based chips and instrumentation for biological research as a biotech tools company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Standard BioTools company profile →
Lino Biotech
HQ: Switzerland
Website
- Description: Provider of focal molography—an entirely new, broadly patented, label-free method for measuring molecular interactions in living cells or crude biological samples—eliminating signal disturbances due to temperature changes or non-specific binding.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lino Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cytoo
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cytoo
2.2 - Growth funds investing in similar companies to Cytoo
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cytoo
4.2 - Public trading comparable groups for Cytoo
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →